GIP
ETON icon

Granite Investment Partners’s Eton Pharmaceutcials ETON Stock Holding History

Granite Investment Partners’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$209K Buy
+8,479
New +$148K 0.01% 233

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Granite Investment Partners's ETON Position: Q1 2026 in Review

Granite Investment Partners opened a new position in Eton Pharmaceutcials (ETON) in Q1 2026: 8,479 shares worth $209K. The stake represents 0.01% of the portfolio and ranks #233 among its holdings.

116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Granite Investment Partners held 8,479 shares of Eton Pharmaceutcials worth $209K as of Q1 2026.
  • Eton Pharmaceutcials was a new Granite Investment Partners position in Q1 2026.
  • Eton Pharmaceutcials made up 0.01% of Granite Investment Partners's portfolio in Q1 2026, its #233 holding.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Granite Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.